HUMA
(NASDAQ)Humacyte, Inc.
$0.60-- (--)
Loading... - Market loading
Humacyte (HUMA) Stock Price & Financial Analysis
Humacyte Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$0.58 - $0.61
52-Week High$2.55
52-Week Low$0.53
Open$0.59
Volume2.95M
Average Volume (3M)7.88M
Market Cap119.68M
Shares Outstanding197.85M
Price to Sales (P/S)59.36
Price to Book (P/B)10.30
EV/EBITDA-1.72
Revenue (TTM)2.02M
Net Income (TTM)-97.59M
Free Cash Flow (TTM)-102.38M
EPS (TTM)$-0.58
Profit Margin-4840.82%
Operating Margin-5649.21%
Return on Equity (ROE)-839.56%
Debt to Equity5.67
50-Day MA$0.67
200-Day MA$0.94
52-Week Change-57.70%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$0.58 - $0.61
52-Week High$2.55
52-Week Low$0.53
Open$0.59
Volume2.95M
Average Volume (3M)7.88M
Market Cap119.68M
Shares Outstanding197.85M
Price to Sales (P/S)59.36
Price to Book (P/B)10.30
EV/EBITDA-1.72
Revenue (TTM)2.02M
Net Income (TTM)-97.59M
Free Cash Flow (TTM)-102.38M
EPS (TTM)$-0.58
Profit Margin-4840.82%
Operating Margin-5649.21%
Return on Equity (ROE)-839.56%
Debt to Equity5.67
50-Day MA$0.67
200-Day MA$0.94
52-Week Change-57.70%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Humacyte
What is the current stock price for HUMA?
As of the latest trading session, HUMA stock trades at $0.60. The 52-week range is $0.53–$2.55, with a day range of $0.58–$0.61.
What is the P/E ratio for HUMA?
The P/E ratio (Price-to-Earnings) for HUMA is shown in the Key Statistics section. This valuation metric helps compare Humacyte, Inc. to industry peers.
Does HUMA pay dividends?
Humacyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for HUMA?
Based on 4 analysts, the consensus for HUMA is Buy.
What is the market cap of HUMA?
Humacyte's market capitalization is $119.7M, classifying it as a micro-cap company. Humacyte operates in the Healthcare sector within the Biotechnology industry.